GSK and Vir Biotechnology announce submission of Emergency Use Authorization request to FDA for…
GlaxoSmithKline plc and Vir Biotechnology, Inc. announced the submission of an application to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA)…
Read More...
Read More...
